BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Religare maintains buy on Glenmark Pharma
Religare cuts target price on Glenmark to Rs 1,040 from Rs 1,370 earlier. Glenmark's Q3 earnings missed estimates by 11 per cent led by a revenue miss across key geographies and higher taxes. The brokerage expects US business to drive performance in the medium term.